Europe Botulinum Toxin Market 2023-2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	118 Pages	Triton Market Research	August, 2023	TRTN18135566

Best Price Guarantee
Price	from $1,500
Length	118 Pages
Publisher	Triton Market Research
Published Date	August, 2023
SKU	TRTN18135566

Europe Botulinum Toxin Market 2023-2030

Market Outlook

Triton Market Research’s report insinuates that the botulinum toxin market in Europe will display a growth rate of 10.20% in revenue during 2023-2030. Italy, the United Kingdom, Germany, Poland, Spain, France, and the Rest of Europe are examined in the given region.

Growing demand for non-surgical injectables in France has fueled the studied market’s growth. This is attributed to the increasing number of professionals specializing in cosmetic procedures, coupled with the expansion of cosmetic clinics. Furthermore, advancements in product development and subsequent approvals by regulatory bodies are expected to play a significant role in driving the growth of the botulinum toxin market throughout the projected period.

Italy hosts one of Europe’s major cosmetic procedure sectors owing to its medical facilities and services. In this regard, individuals from other nations, notably Russia, Romania, and Switzerland, are seeking cosmetic surgery procedures in the country. This has led the Italian Association of Aesthetic Plastic Surgery (AICPE) to form an aesthetic alliance with ISAPS to enhance the quality of cosmetic surgeries and provide heightened patient safety. The rapid expansion of Italy’s healthcare sector is poised to complement the growth of the botulinum toxin market.
Competitive Outlook
The major firms in the botulinum toxin market comprise Ipsen Pharma, Hugel Inc, Candela Medical Corporation, Merz Pharma GmbH & Co KGaA, Revance Therapeutics Inc, and US WorldMeds LLC.

1. Europe Botulinum Toxin Market - Summary
2. Industry Outlook: 2.1. Impact Analysis On The Botulinum Toxin Market; 2.1.1. Covid-19 Impact; 2.2. Key Insights; 2.2.1. Growing Demand For Non-invasive Cosmetic Procedures; 2.2.2. Surge In Demand For Botulinum Toxin Among Millennials And Gen-z; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Regulatory Framework; 2.5. Key Market Strategies; 2.5.1. Product Launches; 2.5.2. Collaborations; 2.5.3. Business Expansions & Divestitures; 2.5.4. Acquisitions; 2.6. Market Drivers; 2.6.1. Surge In Demand For Aesthetic Procedures; 2.6.2. Rise In Geriatric Population; 2.7. Market Challenges; 2.7.1. Limited Reimbursement Policies Supporting Cosmetic Procedures; 2.7.2. Adverse Effects Of Botulinum Toxin; 2.7.3. Emerging Problem Of Botulinum Toxin Type A Resistance; 2.8. Market Opportunities; 2.8.1. Expansion Of Botulinum Toxin Into Therapeutic Applications; 2.8.2. Rising Medical Tourism; 2.9. Analyst Perspective
3. Europe Botulinum Toxin Market Outlook - By Product Type: 3.1. Type A Botulinum Toxin; 3.2. Type B Botulinum Toxin
4. Europe Botulinum Toxin Market Outlook - By Gender: 4.1. Women; 4.2. Men
5. Europe Botulinum Toxin Market Outlook - By Application: 5.1. Aesthetic; 5.1.1. Crow’s Feet; 5.1.2. Forehead Lines; 5.1.3. Frown Lines/Glabellar; 5.1.4. Square Jaw/Masseter; 5.1.5. Other Aesthetic Applications; 5.2. Medical; 5.2.1. Chronic Migraine; 5.2.2. Muscle Spasm; 5.2.3. Overactive Bladder; 5.2.4. Hyperhidrosis; 5.2.5. Other Medical Applications
6. Europe Botulinum Toxin Market Outlook - By End-user: 6.1. Specialty And Dermatology Clinics; 6.2. Hospitals And Clinics; 6.3. Other End-users
7. Europe Botulinum Toxin Market – By Country Outlook: 7.1. Europe; 7.1.1. Market By Product Type; 7.1.2. Market By Gender; 7.1.3. Market By Application; 7.1.3.1. Market By Aesthetic; 7.1.3.2. Market By Medical; 7.1.4. Market By End-user; 7.1.5. Country Analysis; 7.1.5.1. United Kingdom; 7.1.5.1.1. United Kingdom Botulinum Toxin Market Forecast & Prospects; 7.1.5.2. Germany; 7.1.5.2.1. Germany Botulinum Toxin Market Forecast & Prospects; 7.1.5.3. France; 7.1.5.3.1. France Botulinum Toxin Market Forecast & Prospects; 7.1.5.4. Italy; 7.1.5.4.1. Italy Botulinum Toxin Market Forecast & Prospects; 7.1.5.5. Spain; 7.1.5.5.1. Spain Botulinum Toxin Market Forecast & Prospects; 7.1.5.6. Poland; 7.1.5.6.1. Poland Botulinum Toxin Market Forecast & Prospects; 7.1.5.7. Rest Of Europe; 7.1.5.7.1. Rest Of Europe Botulinum Toxin Market Forecast & Prospects
8. Competitive Landscape: 8.1. Abbvie Inc; 8.1.1. Overview; 8.1.2. Product Portfolio; 8.1.3. Key Strengths; 8.1.4. Key Challenges; 8.2. Evolus Inc; 8.2.1. Overview; 8.2.2. Product Portfolio; 8.2.3. Key Strengths; 8.2.4. Key Challenges; 8.3. Medytox Inc; 8.3.1. Overview; 8.3.2. Product Portfolio; 8.3.3. Key Strengths; 8.3.4. Key Challenges; 8.4. Lanzhou Institute Of Biological Products Co Ltd; 8.4.1. Overview; 8.4.2. Product Portfolio; 8.4.3. Key Strengths; 8.4.4. Key Challenges; 8.5. Daewoong Pharmaceutical Co Ltd; 8.5.1. Overview; 8.5.2. Product Portfolio; 8.5.3. Key Strengths; 8.5.4. Key Challenges; 8.6. Galderma Sa; 8.6.1. Overview; 8.6.2. Product Portfolio; 8.6.3. Key Strengths; 8.6.4. Key Challenges; 8.7. Ipsen Pharma; 8.7.1. Overview; 8.7.2. Product Portfolio; 8.7.3. Key Strengths; 8.7.4. Key Challenges; 8.8. Hugel Inc; 8.8.1. Overview; 8.8.2. Product Portfolio; 8.8.3. Key Strengths; 8.8.4. Key Challenges; 8.9. Candela Medical Corporation; 8.9.1. Overview; 8.9.2. Product Portfolio; 8.9.3. Key Strengths; 8.9.4. Key Challenges; 8.10. Merz Pharma Gmbh & Co Kgaa; 8.10.1. Overview; 8.10.2. Product Portfolio; 8.10.3. Key Strengths; 8.10.4. Key Challenges; 8.11. Revance Therapeutics Inc; 8.11.1. Overview; 8.11.2. Product Portfolio; 8.12. Us Worldmeds Llc; 8.12.1. Overview; 8.12.2. Product Portfolio
9. Research Methodology & Scope: 9.1. Research Scope & Deliverables; 9.2. Sources Of Data; 9.3. Research Methodology
List Of Tables: Table 1: Europe Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million); Table 2: Europe Regulatory Framework For Botulinum Toxin; Table 3: List Of Product Launches; Table 4: List Of Collaborations; Table 5: List Of Business Expansions & Divestitures; Table 6: List Of Acquisitions; Table 7: Example Of Commercially Available Botulinum Toxin Type A For Aesthetic Procedures; Table 8: Europe Botulinum Toxin Market, By Product Type, 2023-2030 (In $ Million); Table 9: Europe Botulinum Toxin Market, By Gender, 2023-2030 (In $ Million); Table 10: Europe Botulinum Toxin Market, By Application, 2023-2030 (In $ Million); Table 11: Europe Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Table 12: Europe Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Table 13: Europe Botulinum Toxin Market, By End-user, 2023-2030 (In $ Million); Table 14: Europe Botulinum Toxin Market, By Country Outlook, 2023-2030 (In $ Million)
List Of Figures: Figure 1: Europe Botulinum Toxin Market, By Product Type, 2022 & 2030 (In %); Figure 2: Europe Botulinum Toxin Market, By Type A Botulinum Toxin, 2023-2030 (In $ Million); Figure 3: Europe Botulinum Toxin Market, By Type B Botulinum Toxin, 2023-2030 (In $ Million); Figure 4: Europe Botulinum Toxin Market, By Gender, 2022 & 2030 (In %); Figure 5: Europe Botulinum Toxin Market, By Women, 2023-2030 (In $ Million); Figure 6: Europe Botulinum Toxin Market, By Men, 2023-2030 (In $ Million); Figure 7: Europe Botulinum Toxin Market, By Application, 2022 & 2030 (In %); Figure 8: Europe Botulinum Toxin Market, By Aesthetic, 2023-2030 (In $ Million); Figure 9: Europe Botulinum Toxin Market, By Aesthetic, 2022 & 2030 (In %); Figure 10: Europe Botulinum Toxin Market, By Crow’s Feet, 2023-2030 (In $ Million); Figure 11: Europe Botulinum Toxin Market, By Forehead Lines, 2023-2030 (In $ Million); Figure 12: Europe Botulinum Toxin Market, By Frown Lines/Glabellar, 2023-2030 (In $ Million); Figure 13: Europe Botulinum Toxin Market, By Square Jaw/Masseter, 2023-2030 (In $ Million); Figure 14: Europe Botulinum Toxin Market, By Other Aesthetic Applications, 2023-2030 (In $ Million); Figure 15: Europe Botulinum Toxin Market, By Medical, 2023-2030 (In $ Million); Figure 16: Europe Botulinum Toxin Market, By Medical, 2022 & 2030 (In %); Figure 17: Europe Botulinum Toxin Market, By Chronic Migraine, 2023-2030 (In $ Million); Figure 18: Europe Botulinum Toxin Market, By Muscle Spasm, 2023-2030 (In $ Million); Figure 19: Europe Botulinum Toxin Market, By Overactive Bladder, 2023-2030 (In $ Million); Figure 20: Europe Botulinum Toxin Market, By Hyperhidrosis, 2023-2030 (In $ Million); Figure 21: Europe Botulinum Toxin Market, By Other Medical Applications, 2023-2030 (In $ Million); Figure 22: Europe Botulinum Toxin Market, By End-user, 2022 & 2030 (In %); Figure 23: Europe Botulinum Toxin Market, By Specialty And Dermatology Clinics, 2023-2030 (In $ Million); Figure 24: Europe Botulinum Toxin Market, By Hospitals And Clinics, 2023-2030 (In $ Million); Figure 25: Europe Botulinum Toxin Market, By Other End-users, 2023-2030 (In $ Million); Figure 26: Europe Botulinum Toxin Market, By Country Outlook, 2022 & 2030 (In %); Figure 27: United Kingdom Botulinum Toxin Market 2023-2030 (In $ Million); Figure 28: Germany Botulinum Toxin Market 2023-2030 (In $ Million); Figure 29: France Botulinum Toxin Market 2023-2030 (In $ Million); Figure 30: Italy Botulinum Toxin Market 2023-2030 (In $ Million); Figure 31: Spain Botulinum Toxin Market 2023-2030 (In $ Million); Figure 32: Poland Botulinum Toxin Market 2023-2030 (In $ Million); Figure 33: Rest Of Europe Botulinum Toxin Market 2023-2030 (In $ Million)